Esperion Therapeutics
ESPR
#6609
Rank
โ‚ฌ0.71 B
Marketcap
2,79ย โ‚ฌ
Share price
0.00%
Change (1 day)
184.62%
Change (1 year)

Esperion Therapeutics (ESPR) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚ฌ0.40 Billion

According to Esperion Therapeutics's latest financial reports the company's total assets are โ‚ฌ0.40 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ0.39 B20.03%
2024-12-31โ‚ฌ0.33 B77.48%
2023-12-31โ‚ฌ0.18 B-19.46%
2022-12-31โ‚ฌ0.23 B-31.4%
2021-12-31โ‚ฌ0.33 B17.32%
2020-12-31โ‚ฌ0.28 B50.03%
2019-12-31โ‚ฌ0.19 B52.66%
2018-12-31โ‚ฌ0.12 B-45.85%
2017-12-31โ‚ฌ0.23 B-0.67%
2016-12-31โ‚ฌ0.23 B-13.76%
2015-12-31โ‚ฌ0.27 B129.47%
2014-12-31โ‚ฌ0.11 B107.79%
2013-12-31โ‚ฌ56.69 M925.54%
2012-12-31โ‚ฌ5.52 M229.35%
2011-12-31โ‚ฌ1.67 M
2002-12-31โ‚ฌ49.17 M-44.56%
2001-12-31โ‚ฌ88.7 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
โ‚ฌ182.03 B 44,787.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ35.83 B 8,735.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚ฌ1.13 B 180.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚ฌ0.23 B-41.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.83 B 105.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ7.53 B 1,757.40%๐Ÿ‡บ๐Ÿ‡ธ USA